Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

ON THE PHARMACOLOGY OF N1-PARA-CHLOROPHENYL-N5-ISOPROPYLBIGUANIDE (PALUDRINE)

L. H. SCHMIDT, HETTIE B. HUGHES and CARL C. SMITH
Journal of Pharmacology and Experimental Therapeutics July 1947, 90 (3) 233-253;
L. H. SCHMIDT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HETTIE B. HUGHES
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CARL C. SMITH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

An investigation of the pharmacological properties of Paludrine has been carried out. This has included: (1) evaluation of acute and chronic toxicities in the mouse, rat, dog, and monkey; (2) investigation of absorption, excretion and tissue localization; (3) explorations of pathways of metabolism. A summary of the results of this study follows.

Wide variations in the acute toxicity of Paludrine for different animal species were noted. The mouse is the most susceptible of the experimental animals included in this study. The dog and monkey are the least susceptible, while the rat occupies an intermediary position. There is an 8 to 20 fold difference between the acute toxicity of Paludrine for the mouse and that for the dog or monkey, the variation depending upon the route of administration.

There are somewhat smaller variations in species susceptibility to the chronic toxicity of Paludrine. The dog appears to be the most susceptible of the test animals; the mouse and monkey are next in order, while the rat is least susceptible.

The symptoms of chronic Paludrine intoxication in all 4 animal species are referrable to an as yet undefined effect of the drug on the gastrointestinal tract. This effect results in almost complete loss of appetite leading to death via starvation. Thus far there has been no evidence of toxic effects of Paludrine on specific organs other than those of the enteric tract. Severe toxemias induced by paludrine are readily reversible when treatment is terminated.

Absorption of Paludrine from the gastrointestinal tract is 70 to 90 per cent complete but is rather slow. The drug is localized in the tissues to a comparatively slight degree. At low intakes there is little difference in the concentrations found in various organs and tissues, other than blood plasma. At higher doses, however, Paludrine accumulates in the liver to a greater extent than in other organs. There is some species difference in the deposition of Paludrine in the tissues, the organs of the dog or monkey containing considerably larger amounts of drug than organs of rats receiving comparable doses. Paludrine disappears from the tissues with extreme rapidity when treatment is terminated.

Only a comparatively small fraction of the Paludrine ingested is eliminated in the urine. Since the drug does not accumulate in the tissues, it has been inferred that it must undergo metabolic alteration. Thus far attempts to elucidate the metabolic fate of Paludrine have yielded negative results.

The pharmacological properties of Paludrine have been compared with those of chloroquine and quinacrine and some of the possible advantages of Paludrine have been indicated.

Footnotes

    • Received April 23, 1947.
  • 1946 by The American Society for Pharmacology and Experimental Therapeutics

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 90, Issue 3
1 Jul 1947
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
ON THE PHARMACOLOGY OF N1-PARA-CHLOROPHENYL-N5-ISOPROPYLBIGUANIDE (PALUDRINE)
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

ON THE PHARMACOLOGY OF N1-PARA-CHLOROPHENYL-N5-ISOPROPYLBIGUANIDE (PALUDRINE)

L. H. SCHMIDT, HETTIE B. HUGHES and CARL C. SMITH
Journal of Pharmacology and Experimental Therapeutics July 1, 1947, 90 (3) 233-253;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

ON THE PHARMACOLOGY OF N1-PARA-CHLOROPHENYL-N5-ISOPROPYLBIGUANIDE (PALUDRINE)

L. H. SCHMIDT, HETTIE B. HUGHES and CARL C. SMITH
Journal of Pharmacology and Experimental Therapeutics July 1, 1947, 90 (3) 233-253;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Allosteric Modulation and Accelerated Resensitization of Human P2X3 Receptors by Cibacron Blue
  • Meeting Report for the ASPET–Ray Fuller Symposium: Cellular Mechanisms and Novel Strategies for Pain Control
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics